Kelly Qiao

Kelly Qiao is the Senior Principal at B Capital Group, a venture capital firm that specializes in investing in early-stage companies. Kelly is also a Managing Director at Fosun Group and has been with the company since January 2016.

Qiao has over 15 years of experience in the healthcare and technology industries, with a focus on cross-border investments. Kelly has led investments in cell therapy, biosimilars, drugs, medtech, and digital health companies across the US, UK, and China.

Prior to joining Fosun Group, Kelly was a Managing Director at Taikang Insurance Group Inc., where they oversaw PE investments in healthcare and technology companies. Kelly has also held positions at Insilico Medicine, HiFiBiO Therapeutics, and Beijing Yuanxin Technology Co., Ltd.

Kelly Qiao has a PhD in Biology from Tsinghua University, a Bachelor's degree in Chemistry from Tsinghua University, and an MBA in Finance from The Chinese University of Hong Kong.

Their manager is Daisy Cai, General Partner.